- Molecular characterization of ANKRD1 in rhabdomyosarcoma cell lines: expression, localization, and proteasomal degradation
Emilija Milosevic et al, 2024, Histochemistry and Cell Biology CrossRef - MicroRNAs as Predictors of Future Uterine Malignancy in Endometrial Hyperplasia without Atypia
Chiao-Yun Lin et al, 2022, Journal of Personalized Medicine CrossRef - Knockout of BAX and BAK1 Genes and Overexpression of BCL2, BECN1 Genes Increase Lifespan and the Maximum Density of a CHO-S Cell Culture
S. V. Kovnir et al, 2023, Applied Biochemistry and Microbiology CrossRef - Apigenin, A Plant Flavone Playing Noble Roles in Cancer Prevention Via Modulation of Key Cell Signaling Networks
Deepti Singh et al, 2020, Recent Patents on Anti-Cancer Drug Discovery CrossRef - Human Respiratory Syncytial Virus NS2 Protein Induces Autophagy by Modulating Beclin1 Protein Stabilization and ISGylation
Kim Chiok et al, 2022, mBio CrossRef - Molecular Mechanisms of Autophagy in Cancer Development, Progression, and Therapy
Veronica Angela Maria Vitto et al, 2022, Biomedicines CrossRef - Comparative Study of Extremely Low-Frequency Electromagnetic Field, Radiation, and Temozolomide Administration in Spheroid and Monolayer Forms of the Glioblastoma Cell Line (T98)
Rasoul Yahyapour et al, 2023, Current Radiopharmaceuticals CrossRef - Ginkgo biloba Leaf Polysaccharide Induces Autophagy and Modulates the Expression of Apoptosis Markers in Hepatocellular Carcinoma Cells
K. Li et al, 2024, Molecular Biology CrossRef - MicroRNA-504 functions as a tumor suppressor in oral squamous cell carcinoma through inhibiting cell proliferation, migration and invasion by targeting CDK6
Xiaotang Wang et al, 2020, The International Journal of Biochemistry & Cell Biology CrossRef - The Role of Autophagy Inducer Trehalose in the Cryopreservation of Arterial Endothelial Cells
思杨 黄, 2021, Advances in Clinical Medicine CrossRef - Ferroptosis in Cancer Immunotherapy—Implications for Hepatocellular Carcinoma
Johanna Kusnick et al, 2022, Immuno CrossRef - The Lethality of [Pazopanib + HDAC Inhibitors] Is Enhanced by Neratinib
Laurence Booth et al, 2019, Frontiers in Oncology CrossRef